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The management of critically ill patients is virtually
impossible without intravascular access devices, and about
half of those used in intensive care units (ICUs) are central
venous catheters (CVCs). Unfortunately, these devices
are risk factors for bloodstream and other catheter-related
infections [1, 2], the rates of which are used as markers
for the quality of hospital care over time [3]. Most of these
infections are indeed preventable and have progressively
decreased over the past decade in the USA, from a pooled
mean of 5.0 per 1,000 catheter-days for the 1992–2004
period to 2.9 in 2006 [4]. This may largely be due to
education-based multimodal interventions, which were
incorporated as a key recommendation in the prevention
guidelines [5, 6]. Recent experience confirms the positive
impact of such an approach and strongly suggests that
the objective should now be to eradicate CVC-related
infections [7, 8].
To achieve this goal, important points for which further
evidence has been reported should now be translated into
clinical practice. This is the case for skin disinfection, and
for detailed protocols for insertion and care of CVCs that
should now be standardized and further incorporated into
daily clinical practice. The role of chlorhexidine should be
highlighted. Skin disinfection with alcohol-based solutions
of chlorhexidine may be superior to other agents, includ-
ing alcohol-based iodine solutions [9, 10]. Chlorhexidine-
impregnated dressings may prevent infections, but their
impact should be further investigated [11]. Patient bathing
with chlorhexidine washcloths was also recently reported
to decrease catheter-related infections [12].
Another important component of prevention is surveil-
lance [5]. Traditional methods based on manual review of
clinical and microbiological data are time-consuming and
may not be extended beyond research purposes [13, 14].
Recent data suggest that automated surveillance incorpo-
rating administrative parameters in an algorithm connected
to electronic laboratory survey of bloodstream infections is
accurate in clinical practice [15].
The results reported by Gowardman et al. in this is-
sue [16] further stress the importance of careful insertion
and care of CVCs. Their observational study of 605 short-
term CVCs consecutively inserted in a single Australian
ICU confirms that devices inserted at the subclavian site
are significantly less colonized and that those inserted in
the emergency department are associated with a higher risk
of contamination. Interestingly, they found that the risk
was lower in female patients, particularly at the jugular site
and for coagulase-negative staphylococci.
The rate of bloodstream infection was low and the
study was therefore underpowered to detect differences in
catheter-related infections. Optimal observance of poten-
tially important measures included in the protocol for
insertion and management of the devices may have con-
tributed to this low rate of infection [5, 9]. The absence of
impact on the rate of infection is usually viewed as a limi-
tation, but catheter-tip colonization may be considered as
a surrogate for further infection [17].
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The rates of catheter-related infection have decreased
to levels for which power calculation implies that a suffi-
cient number of CVCs could only be reached with a mul-
ticenter approach [4, 7]. The design of such studies is,
however, limited regarding infection control measures and
detailed technique for catheter insertion and care. In con-
trast, data from prospective cohort studies performed in
single institutions may allow detailed exploration of other
aspects of clinical practice. This is the case in the study
reported by Gowardman et al. [16]. One third of catheters
were antiseptic-coated and were associated with a signif-
icant reduction of colonization at the jugular site. How-
ever, their use was not subject to a protocol, and the “roll-
plate” technique used for culture may have altered these
results [16].
Randomized clinical studies and meta-analyses re-
ported significant reduction of catheter-related infections
with the use of antiseptic- and/or antimicrobial-coated
catheters, but globally, the impact of these devices is in
the same range as those of the educational programs [18].
However, only few prospective cohort studies evaluated
the impact of such devices, which was at least limited
for short-term catheterization and only in the case of
high initial infection rates [19, 20]. Accordingly, coated
devices should not be viewed as magic bullets and until
further evidence is furnished, guidelines and experts
suggest their use only if other measures have failed to
reduce or control catheter-related infections [5, 21]. The
pathophysiology of catheter-related infections includes
a limited number of sources of infection. Infection origi-
nates from colonization of the outer surface of the device,
itself contaminated by the skin flora during insertion or
dressing care. Colonization of the inner surface through
hub’s contamination becomes predominant only after one
week [5, 21].
Differences in structure and properties of the jugular
skin between man and women may explain the differences
in colonization rates reported by Gowardman et al. [16].
A higher number and density of hairs and follicles are
potential sources of microorganisms almost impossible to
eradicate with skin preparation. The continuous growth
of hairs in combination with moisture resulting from
sudation alters rapidly the efficacy of any dressing device
with further increased opportunity for contamination.
Prompt insertion of vascular access devices in patients
with life-threatening conditions cannot be avoided in the
emergency department, where optimal observance of pre-
ventive measures is difficult. However, true central venous
access is rarely mandatory in the emergency department,
and insertion of such devices should be postponed until
transfer of the patient to the operation room or the ICU.
Alternatively, as these higher risks of colonization can be
neglected no longer, extension of the standardization of the
insertion procedure should be extended to the emergency
department when feasible.
To conclude, the data provided by Gowardman et al.
further support the systematic use of the subclavian route
for CVCs in critically ill patients, and postponement of
their insertion until the transfer of the patient to the ICU
or the operating room. This may lead to further progress
along the road to eradication of catheter-related infections
in critically ill patients.
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